Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Kawasaki disease in adults: Observations in France and literature review.
Fraison JB, Sève P, Dauphin C, Mahr A, Gomard-Mennesson E, Varron L, Pugnet G, Landron C, Roblot P, Oziol E, Chalhoub G, Galempoix JM, Humbert S, Humbert P, Sbidian E, Grange F, Bayrou O, Cathebras P, Morlat P, Epaulard O, Pavese P, Huong du LT, Zoulim A, Stankovic K, Bachelez H, Smail A, Bachmeyer C, Granel B, Serratrice J, Brinchault G, Mekinian A, Costedoat-Chalumeau N, Bourgarit-Durand A, Puéchal X, Guillevin L, Piram M, Koné-Paut I, Fain O; CRI and the French Vasculitis Study Group. Fraison JB, et al. Among authors: sbidian e. Autoimmun Rev. 2016 Mar;15(3):242-9. doi: 10.1016/j.autrev.2015.11.010. Epub 2015 Nov 26. Autoimmun Rev. 2016. PMID: 26631821 Free article. Review.
[Adult Kawasaki disease].
Sbidian E, Lacert A, Perrin P, Le Cleach L. Sbidian E, et al. Ann Dermatol Venereol. 2009 Mar;136(3):260-3. doi: 10.1016/j.annder.2008.06.012. Epub 2008 Nov 28. Ann Dermatol Venereol. 2009. PMID: 19328309 French.
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013.
Sbidian E, Hotz C, Seneschal J, Maruani A, Amelot F, Aubin F, Paul C, Beylot Barry M, Humbert P, Dupuy A, Caux F, Dupin N, Modiano P, Lepesant P, Ingen-Housz-Oro S, Mahé E, Bachelez H, Chosidow O, Wolkenstein P. Sbidian E, et al. Br J Dermatol. 2016 Mar;174(3):667-70. doi: 10.1111/bjd.14199. Epub 2015 Dec 22. Br J Dermatol. 2016. PMID: 26406350 Free article. No abstract available.
Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
Mahévas T, Arnulf B, Bouaziz JD, Livideanu CB, Osio A, Servy A, Cribier B, Sassolas B, Jachiet M, Michel L, Aucouturier P, Lipsker D, Frances C, Sbidian E, Rybojad M, Descamps V, D'Incan M, Humbert P, Beylot-Barry M, Passeron T, de Moreuil C, Taha RY, Hermine O, Dupuy A, Barbarot S, Debarbieux S, Carpentier O, Brault F, Schmutz JL, Thomas-Beaulieu D, Modiano P, Zarnitsky C, Lifermann F, Baubion E, Limal N, Le Bras F, Le Moigne M, Tauber M, Talbot A, Prud'homme R, Peltier S, De Masson A, Battistella M, Bagot M, Mékinian A, Fain O. Mahévas T, et al. Among authors: sbidian e. Blood. 2020 Apr 2;135(14):1101-1110. doi: 10.1182/blood.2019002300. Blood. 2020. PMID: 32027747 Free article.
Efficacy and safety of treatments in cutaneous polyarteritis nodosa: A French observational retrospective study.
Bettuzzi T, Jachiet M, Sbidian E, Frumholtz L, Cordoliani F, Mouthon L, Chasset F, Paule R, Bouaziz JD, Guillevin L, Terrier B, Aractingi S, Dupin N, Régent A. Bettuzzi T, et al. Among authors: sbidian e. J Am Acad Dermatol. 2022 May;86(5):1035-1041. doi: 10.1016/j.jaad.2021.06.872. Epub 2021 Jul 2. J Am Acad Dermatol. 2022. PMID: 34224771
Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort.
Bettuzzi T, Bachelez H, Beylot-Barry M, Arlégui H, Paul C, Viguier M, Mahé E, Beneton N, Jullien D, Richard MA, Joly P, Tubach F, Dupuy A, Sbidian E, Chosidow O; PsoBioTeq study group. Bettuzzi T, et al. Among authors: sbidian e. Acta Derm Venereol. 2022 Mar 8;102:adv00665. doi: 10.2340/actadv.v101.566. Acta Derm Venereol. 2022. PMID: 34806759 Free PMC article.
Remission of severe CD8(+) cytotoxic T cell skin infiltrative disease in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
Sbidian E, Battistella M, Rivet J, Flageul B, Molina JM, Joly P, Caumes E, Gorochov G, Cayuela JM, Rabian C, Dupin N, Lebbé C, Janin A, Janier M, Oksenhendler E, Bachelez H. Sbidian E, et al. Clin Infect Dis. 2010 Sep 15;51(6):741-8. doi: 10.1086/655895. Clin Infect Dis. 2010. PMID: 20687841
217 results